JP2016526039A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016526039A5 JP2016526039A5 JP2016515111A JP2016515111A JP2016526039A5 JP 2016526039 A5 JP2016526039 A5 JP 2016526039A5 JP 2016515111 A JP2016515111 A JP 2016515111A JP 2016515111 A JP2016515111 A JP 2016515111A JP 2016526039 A5 JP2016526039 A5 JP 2016526039A5
- Authority
- JP
- Japan
- Prior art keywords
- dexamethasone
- unit dose
- single unit
- days
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361827091P | 2013-05-24 | 2013-05-24 | |
| US61/827,091 | 2013-05-24 | ||
| PCT/US2014/039319 WO2014190248A1 (en) | 2013-05-24 | 2014-05-23 | Use of sustained release dexamethasone in post-cataract surgery inflammation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016526039A JP2016526039A (ja) | 2016-09-01 |
| JP2016526039A5 true JP2016526039A5 (enExample) | 2017-07-06 |
| JP6530744B2 JP6530744B2 (ja) | 2019-06-12 |
Family
ID=51934201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016515111A Active JP6530744B2 (ja) | 2013-05-24 | 2014-05-23 | 白内障手術後の炎症における徐放性デキサメタゾンの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US10028965B2 (enExample) |
| EP (2) | EP3003318B1 (enExample) |
| JP (1) | JP6530744B2 (enExample) |
| KR (1) | KR102245354B1 (enExample) |
| CN (2) | CN105407896B (enExample) |
| AU (1) | AU2014268434B2 (enExample) |
| CA (1) | CA2913336C (enExample) |
| ES (1) | ES2902951T3 (enExample) |
| WO (1) | WO2014190248A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS58825B1 (sr) | 2011-04-25 | 2019-07-31 | Icon Bioscience Inc | Vođice za doziranje za injekcioni špric |
| WO2016196365A1 (en) | 2015-05-29 | 2016-12-08 | Envisia Therapeutics, Inc. | Implant for treatment of an ocular condition |
| TWI765898B (zh) | 2016-06-30 | 2022-06-01 | 美商杜瑞克公司 | 儲積調製劑 |
| US10682340B2 (en) | 2016-06-30 | 2020-06-16 | Durect Corporation | Depot formulations |
| JP2020059652A (ja) * | 2016-12-26 | 2020-04-16 | 参天製薬株式会社 | タフルプロストとクエン酸エステルとを含有するデポ剤 |
| IL276048B2 (en) | 2018-02-09 | 2024-11-01 | Icon Bioscience Inc | Systems, kits and methods for loading and delivering a small volume dose from a syringe |
| WO2020168106A1 (en) | 2019-02-13 | 2020-08-20 | Notable Labs, Inc. | Combinations of agonists of protein kinase c with steroids or retinoic acids for the treatment of cancer |
| IT201900003529A1 (it) * | 2019-03-11 | 2020-09-11 | Ntc S R L | Riduzione della posologia antibiotica in composizioni antibiotico/antinfiammatorio in associazione tra loro per uso oftalmico |
| US11911499B2 (en) | 2019-11-07 | 2024-02-27 | Resurge Therapeutics, Inc. | System and method for prostate treatment |
| US11602516B1 (en) | 2022-01-29 | 2023-03-14 | Resurge Therapeutics Inc. | Treating benign prostatic hyperplasia |
| US11957654B2 (en) | 2022-01-29 | 2024-04-16 | Resurge Therapeutics, Inc. | Treating benign prostatic hyperplasia |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4211793A (en) | 1979-03-19 | 1980-07-08 | American Cyanamid Company | Triethyl citrate solutions of PGE-type compounds |
| DE3500103C2 (de) | 1985-01-04 | 1987-01-22 | R.P. Scherer GmbH, 6930 Eberbach | Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff |
| US4889845A (en) | 1986-06-09 | 1989-12-26 | American Cyanamid Company | Vehicle for topical application of pharmaceuticals |
| AU5178193A (en) | 1992-11-09 | 1994-06-08 | Quest International B.V. | Solubilizing agents |
| US5747058A (en) | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
| US20040024006A1 (en) | 1996-05-06 | 2004-02-05 | Simon David Lew | Opioid pharmaceutical compositions |
| US20030216303A1 (en) | 1998-03-06 | 2003-11-20 | Michael Ambuhl | Emulsion preconcentrates containing cyclosporin or a macrolide |
| US6468559B1 (en) | 2000-04-28 | 2002-10-22 | Lipocine, Inc. | Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods |
| AU2001245346A1 (en) | 2000-06-28 | 2002-01-08 | Atul J. Shukla | Biodegradable vehicles and delivery systems of biologically active substances |
| US6726918B1 (en) * | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
| US6960346B2 (en) | 2002-05-09 | 2005-11-01 | University Of Tennessee Research Foundation | Vehicles for delivery of biologically active substances |
| US20040253293A1 (en) * | 2003-06-16 | 2004-12-16 | Afshin Shafiee | Rate controlled release of a pharmaceutical agent in a biodegradable device |
| ITMI20032087A1 (it) | 2003-10-27 | 2005-04-28 | Pharmafilm S R L | Film autosupportanti per uso farmaceutico ed alimentare. |
| US9016221B2 (en) | 2004-02-17 | 2015-04-28 | University Of Florida Research Foundation, Inc. | Surface topographies for non-toxic bioadhesion control |
| US20080038316A1 (en) | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
| US8541413B2 (en) | 2004-10-01 | 2013-09-24 | Ramscor, Inc. | Sustained release eye drop formulations |
| CN101890167B (zh) | 2004-10-01 | 2017-03-01 | 拉姆斯科股份有限公司 | 可方便植入的缓释药物组合物 |
| US8313763B2 (en) | 2004-10-04 | 2012-11-20 | Tolmar Therapeutics, Inc. | Sustained delivery formulations of rapamycin compounds |
| US9149439B2 (en) | 2005-03-21 | 2015-10-06 | Sandoz Ag | Multi-particulate, modified-release composition |
| EP2266638A3 (de) | 2009-06-25 | 2014-08-13 | Biotronik VI Patent AG | Biokorrodierbares Implantat mit einer aktiven Beschichtung |
| WO2011081712A1 (en) | 2009-12-31 | 2011-07-07 | Boston Scientific Scimed, Inc. | Cryo activated drug delivery and cutting balloons |
| RS58825B1 (sr) | 2011-04-25 | 2019-07-31 | Icon Bioscience Inc | Vođice za doziranje za injekcioni špric |
| EP2717914B1 (en) * | 2011-06-10 | 2019-10-30 | Ramscor, Inc. | Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
| AU2012325370A1 (en) | 2011-06-10 | 2014-01-30 | Ramscor, Inc. | Conveniently injectable or implantable sustained-release antioxidant formulations for therapies of ocular maladies or cancer |
| ES2908977T3 (es) | 2013-06-03 | 2022-05-04 | Mcneil Ab | Forma de dosificación farmacéutica sólida para liberar en la cavidad oral al menos dos ingredientes farmacéuticos activos |
-
2014
- 2014-05-23 CN CN201480041856.1A patent/CN105407896B/zh active Active
- 2014-05-23 ES ES14800446T patent/ES2902951T3/es active Active
- 2014-05-23 WO PCT/US2014/039319 patent/WO2014190248A1/en not_active Ceased
- 2014-05-23 EP EP14800446.8A patent/EP3003318B1/en active Active
- 2014-05-23 CN CN201910639315.3A patent/CN110339153A/zh active Pending
- 2014-05-23 AU AU2014268434A patent/AU2014268434B2/en active Active
- 2014-05-23 JP JP2016515111A patent/JP6530744B2/ja active Active
- 2014-05-23 US US14/893,381 patent/US10028965B2/en active Active
- 2014-05-23 CA CA2913336A patent/CA2913336C/en active Active
- 2014-05-23 KR KR1020157036698A patent/KR102245354B1/ko active Active
- 2014-05-23 EP EP21215082.5A patent/EP4082525A1/en not_active Withdrawn
-
2018
- 2018-06-26 US US16/018,931 patent/US10159683B2/en active Active
- 2018-12-10 US US16/215,579 patent/US20190105330A1/en not_active Abandoned
-
2022
- 2022-09-20 US US17/948,842 patent/US20230078906A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016526039A5 (enExample) | ||
| TWI705820B (zh) | Gip/glp1促效劑組合物 | |
| JP5882993B2 (ja) | 抗精神病薬デポ型注射用組成物 | |
| JP6896015B2 (ja) | 注射速度が増大したアリピプラゾール調合物 | |
| AR064078A1 (es) | Sistema de administracion de farmacos intraocular inyectable biocompatible, su uso para preparar un medicamento y proceso para su preparacion | |
| KR102055937B1 (ko) | 불용성 코르티코스테로이드 및 수용성 코르티코스테로이드를 포함하는 약학적 제형 | |
| JP2010511596A5 (enExample) | ||
| BRPI0909630B1 (pt) | Composição em suspensão aquosa particularmente adequada para injeção dentro do olho | |
| AR081575A1 (es) | Formas de dosificacion oral de bendamustina y su uso terapeutico | |
| ES2902951T3 (es) | Uso de dexametasona de liberación sostenida en la inflamación después de cirugía de cataratas | |
| EA029921B1 (ru) | Депо-композиция палиперидона с замедленным высвобождением, способ ее получения и способ психиатрического лечения с использованием этой композиции | |
| RU2015109296A (ru) | Системы доставки лекарственного средства и способы лечения рака мочевого пузыря, включающие применение оксалиплатина | |
| JP2011517311A (ja) | 麻酔薬組成物、製剤及び使用方法 | |
| JP2018522920A5 (enExample) | ||
| CN103705910B (zh) | 一种齐考诺肽注射型皮下植入剂及其制备方法 | |
| CN103877005A (zh) | 一种复方奥氮平皮下埋植缓释剂 | |
| EP3331509A1 (en) | Stable liquid injectable solution of midazolam and pentazocine | |
| CN100379420C (zh) | 一种用于戒毒的长效缓释制剂及其制备方法和用途 | |
| RU2581022C1 (ru) | Противоопухолевые фармацевтические композиции и способ лечения рака молочной железы | |
| CN103989685A (zh) | 一种复方拉莫三嗪皮下埋植缓释胶棒的制备方法 | |
| CN105943578A (zh) | 鹿用肌肉注射复合麻醉剂及其制备方法 | |
| JP2016503406A5 (enExample) | ||
| CA2994748C (en) | Pharmaceutical composition comprising sumatripan for treating migraine | |
| CN103877004A (zh) | 一种复方利培酮皮下埋植缓释剂及其制备方法 | |
| CN108309932A (zh) | 一种肌肉注射用青蒿琥酯的溶剂 |